EMEA-002755-PIP01-19-M01
Key facts
Active substance |
Fully human IgG1 RB-1 YTE anti-RSV F monoclonal antibody (MK-1654)
|
Therapeutic area |
Infectious diseases
|
Decision number |
P/0554/2021
|
PIP number |
EMEA-002755-PIP01-19-M01
|
Pharmaceutical form(s) |
Solution for injection
|
Condition(s) / indication(s) |
Prevention of lower respiratory tract infection caused by respiratory syncytial virus
|
Route(s) of administration |
Intramuscular use
|
Contact for public enquiries |
Merck Sharp & Dohme (Europe), Inc.
Tel. +33 180464738 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|